ArticleMolecular and cellular biochemistry2017

Inhibition of protein kinase CK2 sensitizes non-small cell lung cancer cells to cisplatin via upregulation of PML.

Bo Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.